Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Logo for Transform Dementia

Congratulations to Postdoctoral Research Associate, Michele Veldsman, who has received a grant from the Race Against Dementia Seed Fund. The grant will fund the first year pilot of the initiative, Transform Dementia Research (TDR), a new non-profit social enterprise that aims to transform how dementia research is carried out and accelerate discovery.

The cross-disciplinary and industry team behind TDR – co-led by Michele Veldsman and Hugo Fernandes (University of Cambridge) – is made up of neuroscientists from the University of Oxford, the University of Cambridge, the University of Exeter and a former Formula 1 engineer. They have come together to radically revolutionise the way dementia research is done, taking inspiration from the speed of innovation, problem-solving and teamwork in Formula 1.

Michele Veldsman said: I am excited to co-lead Transform Dementia Research, which is aiming to completely change how we do dementia research. We want to find the biggest questions that need to be answered to accelerate discovery, then build cross-discipline, cross-industry teams to tackle these questions. We are taking inspiration from Formula 1, where teams work towards a single goal, innovating at incredible speed. We will encourage rigorous, innovative and open collaboration to bring real impacts to patients’ lives.

 

Race Against Dementia is a charity founded by F1 legend Sir Jackie Stewart.

Find out more.

Similar stories

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

New Academic Visitor from Nigeria

Associate Professor of Radiology, Godwin Ogbole has arrived on a six-month visit to the Nuffield Department of Clinical Neurosciences, as part of the Africa Oxford Initiative.

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

Protein test could lead to earlier and better diagnosis of Parkinson’s

Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.